GDRX:NSD-GoodRx Holdings, Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 40.15

Change

+0.69 (+1.75)%

Market Cap

USD 15.85B

Volume

1.14M

Average Target Price

USD 49.00 (+22.04%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools to enables consumers compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that can be used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-09 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CERN Cerner Corporation

+0.59 (+0.82%)

USD21.98B 28.86 13.16
TXG 10x Genomics, Inc

+4.40 (+2.31%)

USD20.73B N/A N/A
CHNG Change Healthcare Inc

+0.01 (+0.04%)

USD6.90B N/A N/A
RCM R1 RCM Inc

+0.29 (+1.15%)

USD6.57B 76.85 33.59
OMCL Omnicell, Inc

+1.01 (+0.76%)

USD5.67B 180.65 53.88
HQY HealthEquity, Inc

+1.78 (+2.64%)

USD5.61B 567.65 40.62
INOV Inovalon Holdings, Inc

N/A

USD4.65B 205.14 29.21
PINC Premier, Inc

+0.19 (+0.56%)

USD4.16B 13.34 10.25
PGNY Progyny, Inc

+1.74 (+3.80%)

USD4.06B 792.68 380.22
CVET Covetrus, Inc

-0.55 (-1.88%)

USD3.98B 40.87 22.26

ETFs Containing GDRX

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.47% 29% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.47% 29% F 29% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 15.85B 93% A 93% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 927.27 9% F 2% F
Price/Book Ratio 22.06 15% F 7% F
Price / Cash Flow Ratio 120.71 7% F 5% F
EV/EBITDA 238.21 21% F 5% F
Management Effectiveness  
Return on Equity -162.77% 7% F 7% F
Return on Invested Capital -55.30% 14% F 15% F
Return on Assets -18.00% 13% F 21% F
Debt to Equity Ratio 92.76% 20% F 23% F
Technical Ratios  
Short Ratio 5.46 27% F 17% F
Short Percent 18.40% 7% F 9% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector